Abstract:It is now well established that in yeast, and likely most eukaryotic organisms, initial DNA replication of the leading strand is by DNA polymerase ε and of the lagging strand by DNA polymerase δ. However, the role of Pol δ in replication of the leading strand is uncertain. In this work, we use a reporter system in Saccharomyces cerevisiae to measure mutation rates at specific base pairs in order to determine the effect of heterozygous or homozygous proofreading-defective mutants of either Pol ε or Pol δ in dip… Show more
“…Most previous experimental studies confirm the classical model, including experiments with mutant polymerases (Pursell et al 2007;Kunkel and Burgers 2008;Nick McElhinny et al 2008;Johnson et al 2015) or incorporation of ribonucleotides Clausen et al 2015;Johnson et al 2015), where specific mutations were observed on the corresponding strands; experiments investigating the association of proteins with leading and lagging strands of DNA replication forks (Yu et al 2014); and biochemical experiments of assembly and stabilization of replication complexes (Georgescu et al , 2015Langston et al 2014). Moreover, recent evidence suggests that Pol epsilon does not proofread errors made by Pol delta (Flood et al 2015). This model (Johnson et al 2015) also contradicts our data, as it does not predict the opposite strand biases we observe in cancers with mutated Pol epsilon and Pol delta (Fig.…”
Mismatch repair (MMR) is one of the main systems maintaining fidelity of replication. Differences in correction of errors produced during replication of the leading and the lagging DNA strands were reported in yeast and in human cancers, but the causes of these differences remain unclear. Here, we analyze data on human cancers with somatic mutations in two of the major DNA polymerases, delta and epsilon, that replicate the genome. We show that these cancers demonstrate a substantial asymmetry of the mutations between the leading and the lagging strands. The direction of this asymmetry is the opposite between cancers with mutated polymerases delta and epsilon, consistent with the role of these polymerases in replication of the lagging and the leading strands in human cells, respectively. Moreover, the direction of strand asymmetry observed in cancers with mutated polymerase delta is similar to that observed in MMR-deficient cancers. Together, these data indicate that polymerase delta (possibly together with polymerase alpha) contributes more mismatches during replication than its leading-strand counterpart, polymerase epsilon; that most of these mismatches are repaired by the MMR system; and that MMR repairs about three times more mismatches produced in cells during lagging strand replication compared with the leading strand.
“…Most previous experimental studies confirm the classical model, including experiments with mutant polymerases (Pursell et al 2007;Kunkel and Burgers 2008;Nick McElhinny et al 2008;Johnson et al 2015) or incorporation of ribonucleotides Clausen et al 2015;Johnson et al 2015), where specific mutations were observed on the corresponding strands; experiments investigating the association of proteins with leading and lagging strands of DNA replication forks (Yu et al 2014); and biochemical experiments of assembly and stabilization of replication complexes (Georgescu et al , 2015Langston et al 2014). Moreover, recent evidence suggests that Pol epsilon does not proofread errors made by Pol delta (Flood et al 2015). This model (Johnson et al 2015) also contradicts our data, as it does not predict the opposite strand biases we observe in cancers with mutated Pol epsilon and Pol delta (Fig.…”
Mismatch repair (MMR) is one of the main systems maintaining fidelity of replication. Differences in correction of errors produced during replication of the leading and the lagging DNA strands were reported in yeast and in human cancers, but the causes of these differences remain unclear. Here, we analyze data on human cancers with somatic mutations in two of the major DNA polymerases, delta and epsilon, that replicate the genome. We show that these cancers demonstrate a substantial asymmetry of the mutations between the leading and the lagging strands. The direction of this asymmetry is the opposite between cancers with mutated polymerases delta and epsilon, consistent with the role of these polymerases in replication of the lagging and the leading strands in human cells, respectively. Moreover, the direction of strand asymmetry observed in cancers with mutated polymerase delta is similar to that observed in MMR-deficient cancers. Together, these data indicate that polymerase delta (possibly together with polymerase alpha) contributes more mismatches during replication than its leading-strand counterpart, polymerase epsilon; that most of these mismatches are repaired by the MMR system; and that MMR repairs about three times more mismatches produced in cells during lagging strand replication compared with the leading strand.
“…Given evidence that the exonuclease activity of Pol δ, but not that of Pol ε, proofreads errors made by Pol α[12], and evidence that Pol δcan also proofread errors made by Pol ε [13], the higher mutation rate in the pol3-exo -
msh6 Δ strain could be due to loss Pol δ proofreading of errors made by any of the three replicases, whereas loss Pol ε may only proofread its own errors. The different mutation rates in the pol3-exo -
msh6 Δ and pol2-exo -
msh6 Δ strains could also be related to differences in activation of the S phase checkpoint in proofreading-deficient strains (see [26] and references therein).…”
Section: Resultsmentioning
confidence: 99%
“…Thus it is possible that in the absence of only one of the two proofreading activities intrinsic to Pol ε and Pol δ, the exonuclease that remains intact in one replicase can proofread mismatches generated by the other major, but proofreading-deficient replicase [2,12]. Indeed, a recent study [13] provides evidence that Pol δ proofreads errors made by Pol ε. Theoretically, extrinsic proofreading may also be catalyzed by other 3′-exonucleases (e.g., see [52]). To the extent that extrinsic proofreading may occur during replication in yeast, this implies that (i) the actual base selectivity of the replicases in vivo could be substantially lower than calculated here, and therefore more in line with the estimates from studies in vitro , and (ii) the base selectivity calculated here for lagging strand replication may be a mixture of the base selectivity of Pol α plus Pol ε, because both polymerases contribute to the mature lagging strand (see [21,53], and more recently [5,8]).…”
Section: Resultsmentioning
confidence: 99%
“…Moreover, there is evidence to suggest that the exonuclease activity of Pol δ, but not that of Pol ε, likely proofreads errors made by Pol α during lagging strand replication [12], and more recent evidence that Pol δ can proofread errors made by Pol ε [13]. Not only is proofreading more complicated in yeast as compared to E. coli , but so too is eukaryotic MMR more complicated than in E. coli .…”
Mismatches generated during eukaryotic nuclear DNA replication are removed by two evolutionarily conserved error correction mechanisms acting in series, proofreading and mismatch repair (MMR). Defects in both processes are associated with increased susceptibility to cancer. To better understand these processes, we have quantified base selectivity, proofreading and MMR during nuclear DNA replication in Saccharomyces cerevisiae. In the absence of proofreading and MMR, the primary leading and lagging strand replicases, polymerase ε and polymerase δ respectively, synthesize DNA in vivo with somewhat different error rates and specificity, and with apparent base selectivity that is more than 100 times higher than measured in vitro. Moreover, leading and lagging strand replication fidelity rely on a different balance between proofreading and MMR. On average, proofreading contributes more to replication fidelity than does MMR, but their relative contributions vary from nearly all proofreading of some mismatches to mostly MMR of other mismatches. Thus accurate replication of the two DNA strands results from a non-uniform and variable balance between error prevention, proofreading and MMR.
“…Polε exonuclease deficiency results in a very small increase in the mutation rate in both yeast and human cells [8,83,84], even though the fidelity of purified Polε in vitro is strongly affected by the inactivation of proofreading [85,86]. It has been suggested that the majority of Polε errors are corrected in cells by extrinsic mechanisms, for example, by the exonuclease activity of Polδ [2,87]. On the other hand, many Polε exonuclease domain mutations found in cancers, and particularly P286R, were predicted to affect DNA binding [23,24,63].…”
Section: Mechanisms Of the Ultramutator Phenotypementioning
The fidelity of DNA replication relies on three error avoidance mechanisms acting in series: nucleotide selectivity of replicative DNA polymerases, exonucleolytic proofreading, and post-replicative DNA mismatch repair (MMR). MMR defects are well known to be associated with increased cancer incidence. Due to advances in DNA sequencing technologies, the past several years have witnessed a long-predicted discovery of replicative DNA polymerase defects in sporadic and hereditary human cancers. The polymerase mutations preferentially affect conserved amino acid residues in the exonuclease domain and occur in tumors with an extremely high mutation load. Thus, a concept has formed that defective proofreading of replication errors triggers the development of these tumors. Recent studies of the most common DNA polymerase variants, however, suggested that their pathogenicity may be determined by functional alterations other than loss of proofreading. In this review, we summarize our current understanding of the consequences of DNA polymerase mutations in cancers and the mechanisms of their mutator effects. We also discuss likely explanations for a high recurrence of some but not other polymerase variants and new ideas for therapeutic interventions emerging from the mechanistic studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.